Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Juraschek, Stephen P ^a,b   Shantha, Ghanshyam Palamaner Subash ^b   Chu, Audrey Y ^c   Miller III, Edgar R ^b,d   Guallar, Eliseo ^a,b,d   Hoogeveen, Ron C ^e,f   Ballantyne, Christie M ^e,f   Brancati, Frederick L ^a,b,d   Schmidt, Maria Inês ^g,h   Pankow, James S ⁱ   Young, J Hunter ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^g FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^h IL   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LACTIC ACID; LIPID;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL EVALUATION; COHORT ANALYSIS; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RISK ASSESSMENT;

ATHEROSCLEROSIS; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LACTIC ACID; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RISK;

EID: 84873869152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055113     Document Type: Article

References (54)

1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, et al. (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29: 1263-8.
2. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-92.
3. Bernal-Mizrachi C, Semenkovich CF, (2006) Fast predators or fast food, the fit still survive. Nat Med 12: 46-47.
4. Kreisberg RA, (1980) Lactate homeostasis and lactic acidosis. Ann Intern Med 92(2 Pt 1): 227-37.
5. Iossa S, Mollica MP, Lionetti L, Crescenzo R, Tasso R, et al. (2004) A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance. Diabetes 53: 2861-6.
6. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-2.
7. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR, (1990) Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85: 522-9.
8. Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, et al. (2006) Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 290: E67-E77.
9. Chen YD, Varasteh BB, Reaven GM, (1993) Plasma lactate concentration in obesity and type 2 diabetes. Diabete Metab 19: 348-54.
10. Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M, (1992) Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metab Clin Exp 41: 22-7.
11. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD, (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-4.
12. Crawford SO, Hoogeveen RC, Brancati FL, Astor BC, Ballantyne CM, et al. (2010) Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol 39: 1647-55.
13. Ohlson LO, Larsson B, Björntorp P, Eriksson H, Svärdsudd K, et al. (1988) Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31: 798-805.
14. The ARIC investigators, (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129: 687-702.
15. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, et al. (1996) Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. J Clin Epidemiol 49: 1441-6.
16. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, et al. (1996) Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 49: 223-33.
17. Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, et al. (2010) High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J Clin Endocrinol Metab 95: 5097-104.
18. Barham D, Trinder P, (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97: 142-5.
19. Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, et al. (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 27: 77-82.
20. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, et al. (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-805.
21. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, et al. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353: 1649-52.
22. Arieff AI, Graf H, (1987) Pathophysiology of type A hypoxic lactic acidosis in dogs. Am J Physiol 253(3 Pt 1): E271-276.
23. Gladden LB, (2008) A lactatic perspective on metabolism. Med Sci Sports Exerc 40: 477-85.
24. Qvisth V, Hagström-Toft E, Moberg E, Sjöberg S, Bolinder J, (2007) Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am J Physiol Endocrinol Metab 292: E709-714.
25. Yki-Järvinen H, Bogardus C, Foley JE, (1990) Regulation of plasma lactate concentration in resting human subjects. Metab Clin Exp 39: 859-64.
26. Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, Gerich JE, (1990) Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am J Physiol 259(5 Pt 1): E677-684.
27. Brecher AS, Lehti MD, (1996) A hypothesis linking hypoglycemia, hyperuricemia, lactic acidemia, and reduced gluconeogenesis in alcoholics to inactivation of glucose-6-phosphatase activity by acetaldehyde. Alcohol 13: 553-7.
28. Stefanovski D, Youn JH, Rees M, Watanabe RM, Ader M, et al. (2012) Estimating hepatic glucokinase activity using a simple model of lactate kinetics. Diabetes Care 35: 1015-20.
29. Howell RR, (1965) The interrelationship of glycogen storage disease and gout. Arthritis Rheum 8: 780-5.
30. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-11.
31. Avogaro A, Toffolo G, Miola M, Valerio A, Tiengo A, et al. (1996) Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 98: 108-15.
32. Sandqvist MM, Eriksson JW, Jansson PA, (2001) Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes. Diabetes 50: 2344-8.
33. Crandall DL, Fried SK, Francendese AA, Nickel M, DiGirolamo M, (1983) Lactate release from isolated rat adipocytes: influence of cell size, glucose concentration, insulin and epinephrine. Horm Metab Res 15: 326-9.
34. Ye J, (2011) Adipose tissue vascularization: its role in chronic inflammation. Curr Diab Rep 11: 203-10.
35. Björntorp P, Scherstén T, Fagerberg SE, (1967) Respiration and phosphorylation of mitochondria isolated from the skeletal muscle of diabetic and normal subjects. Diabetologia 3: 346-52.
36. Kelley DE, He J, Menshikova EV, Ritov VB, (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-50.
37. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, et al. (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115: 3587-93.
38. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA, (2000) Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-1044.
39. Hoeks J, van Herpen NA, Mensink M, Moonen-Kornips E, van Beurden D, et al. (2010) Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 59: 2117-25.
40. Cheng Z, Tseng Y, White MF, (2010) Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21: 589-98.
41. Holloszy JO, (2009) Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 89: 463S-6S.
42. Irving BA, Short KR, Nair KS, Stump CS, (2011) Nine days of intensive exercise training improves mitochondrial function but not insulin action in adult offspring of mothers with type 2 diabetes. J Clin Endocrinol Metab 96: E1137-1141.
43. Østergård T, Andersen JL, Nyholm B, Lund S, Nair KS, et al. (2006) Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 290: E998-1005.
44. Dela F, Stallknecht B, (2010) Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 299: E80-91.
45. Pravenec M, Hyakukoku M, Houstek J, Zidek V, Landa V, et al. (2007) Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res 17: 1319-26.
46. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, et al. (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-9.
47. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, et al. (1992) Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1: 368-71.
48. Pagel-Langenickel I, Bao J, Pang L, Sack MN, (2010) The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev 31: 25-51.
49. Toledo FGS, Menshikova EV, Ritov VB, Azuma K, Radikova Z, et al. (2007) Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56: 2142-7.
50. Skov V, Glintborg D, Knudsen S, Tan Q, Jensen T, et al. (2008) Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome. PLoS ONE 3: e2466.
51. Watson RT, Kanzaki M, Pessin JE, (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25: 177-204.
52. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, et al. (1997) GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3: 1096-1101.
53. Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G, et al. (2005) Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48: 132-139.
54. Choi CS, Kim YB, Lee FN, Zabolotny JM, Kahn BB, et al. (2002) Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. Am J Physiol Endocrinol Metab 283: E233-240.